ANTIDIABETIC DRUG APPROVED TO REDUCE RISK OF KIDNEY DISEASE

被引:0
|
作者
Aschenbrenner, Diane S. [1 ,2 ]
机构
[1] Notre Dame Maryland Univ, Baltimore, MD 21210 USA
[2] Johns Hopkins Univ, Sch Nursing, Baltimore, MD 21218 USA
关键词
D O I
暂无
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
引用
收藏
页码:25 / 25
页数:1
相关论文
共 50 条
  • [31] Drug-eluting stent implantations in patients with chronic kidney disease are useful to reduce revascularization
    Jeong, Young-Hoon
    Hong, Myeong-Ki
    Park, Duk-Woo
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 133 (02) : 247 - 248
  • [32] Diabetes treatment with oral antidiabetic drugs in chronic kidney disease
    Merker, L.
    Kleophas, W.
    NEPHROLOGE, 2018, 13 (06): : 425 - 434
  • [33] Computational drug repurposing to predict approved and novel drug-disease associations
    Khalid, Zoya
    Sezerman, Osman Ugur
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2018, 85 : 91 - 96
  • [34] Lifestyle Recommendations to Reduce the Risk of Kidney Stones
    Meschi, Tiziana
    Nouvenne, Antonio
    Borghi, Loris
    UROLOGIC CLINICS OF NORTH AMERICA, 2011, 38 (03) : 313 - +
  • [35] Antidiabetic Drugs and the Kidney
    Tsimihodimos, Vasilis
    Karanatsis, Nikolaos
    Tzavela, Eleftheria
    Elisaf, Moses
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (41) : 6310 - 6320
  • [37] Drug repurposing in kidney disease
    Panchapakesan, Usha
    Pollock, Carol
    KIDNEY INTERNATIONAL, 2018, 94 (01) : 40 - 48
  • [38] NEW TYPE 2 DIABETES DRUG AIMS TO REDUCE RISK OF DIMINISHED KIDNEY FUNCTION AND CARDIOVASCULAR COMPLICATIONS
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2021, 121 (11) : 22 - 23
  • [39] Drug therapy in kidney disease
    Aronson, Jeffrey K.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (05) : 509 - 511
  • [40] Sugar restriction: the evidence for a drug-free intervention to reduce cardiovascular disease risk
    Thornley, S.
    Tayler, R.
    Sikaris, K.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 46 - 58